Y. Hartmanna, M. Dabrosb, R. Pierrec, C. Rhêmec, X. Gaoc aHES de Fribourg, Bd de Pérolles 80, 1700 Fribourg, Switzerland, yves.hartmann@hefr.ch bHES de Fribourg, Bd de Pérolles 80, 1700 Fribourg, Switzerland, michal.dabros@hefr.ch Lactobacillus plantarum is a widely recognized probiotic microorganism, […]
Influence of high-energy milling on the biological activity of microbial particles. Read More »
The American Academy of Neurology (AAN) Annual Meeting 2025 took place in San Diego, California on April 5-9, 2025. This prestigious gathering served as a pivotal platform for neurological advancements, featuring 1,272 total presentations, including 215 industry-sponsored sessions. The conference
American Academy of Neurology (AAN) Annual Meeting 2025 Read More »
Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of Longidaza (3000 U) for treating long-term pulmonary complications associated with COVID-19. The trial, which enrolled 392 patients across 37 clinical
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the delivery of preventative care interventions and address critical pressures facing the NHS. Featuring insights from EMIS’s Jamie Cole, director of
Transforming preventative care in the NHS Read More »
Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract manufactures have a duty to engage with the science-based climate targets, says ACG. Source link Nikki Thompson
The growing role of CDMOs in the circular economy Read More »
Despite their potential to revolutionise medicine, stem cell therapies have long faced scepticism within the pharmaceutical industry. Concerns about the scientific complexity, regulatory hurdles, and clinical failures have contributed to a cautious approach. However, perspectives are shifting as advancements in
